Results 141 to 150 of about 7,197,295 (300)

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

Self and Peer Assessment

open access: yes, 2015
Successful students are often good at reviewing and evaluating their own performance, as well as that of their peers. Self and peer assessment are therefore important parts of students' study strategies, allowing them to take greater control of their ...
Brown, Gavin
core  

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez   +10 more
wiley   +1 more source

Self-harm in young people: A therapeutic assessment method

open access: yes, 2009
Features: Uses a novel Therapeutic Assessment approach to young people presenting with self-harm, developed by the authors. Includes generous use of case examples and illustrations throughout, and "key points" boxes to emphasize the most ...
Ougrin, Dennis   +2 more
core  

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Evaluative misalignment of 10th-grade student and teacher criteria for essay quality: An automated textual analysis

open access: yesJournal of Writing Research, 2013
Writing is a necessary skill for success in the classroom and the workplace; yet, many students are failing to develop sufficient skills in this area. One potential problem may stem from a misalignment between students' and teachers' criteria for quality
Laura K. Varner, Rod D. Roscoe & Danielle S. McNamara
doaj  

Self- and peer-assessment in collaborative writing: Findings on motivational-emotional aspects, usability and usage patterns

open access: yes, 2013
With the growing demands on learners in modern e-learning environments, new ways for social learning and corresponding assessments have to be developed.
Gütl, Christian   +2 more
core  

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos   +9 more
wiley   +1 more source

Implementing the Schneider Performance System. A lean self-assessment model in Schneider Electric

open access: yes
reservedQuesta tesi affronta lo studio e l'applicazione di un modello di self-assessment sulla metodologia Lean proprio del gruppo Schneider Electric, chiamato SPS (Schneider Performance System). La tesi studia i principi su cui si basa l'SPS e le regole
BATTISTELLO, SARA
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy